Consensus Genpact Limited Deutsche Boerse AG

Stocks

35G

BMG3922B1072

Business Support Services

Real-time Estimate Tradegate 12:16:44 06/10/2026 BST			5-day change	1st Jan Change
29.90 ^EUR	+1.22%		+4.46%	-26.35%

09-16	Genpact Insider Sold Shares Worth $367,900, According to a Recent SEC Filing	MT
09-08	Genpact Announces CFO Changes	CI

df271f48dc9c917642a4f.FOpQhajQdtCyNsy_m7Yelq_EGU6FR6XGmE-_MJL7B-U.e68j6ePiHoHRc7qNqPNq4-eBUgHdIu2B3BjuY9uiY713mx6ozrUftodOpw~79c1429f9ac79d7f9f27c4e2d601a0af

Analysts' recommendations: Genpact Limited

08-07	Analyst recommendations: Micron Technology, Lockheed Martin, Airbnb, Johnson Controls International, The Allstate Corporation…
05-11	Mizuho Securities Adjusts Genpact Price Target to $39 From $49, Maintains Neutral Rating	MT
12-12	Susquehanna Initiates Genpact With Neutral Rating, $50 Price Target	MT
07/08/25	Genpact Q2 revenue, adjusted profit beats estimates	RE
27/06/25	TD Cowen Raises Price Target on Genpact to $55 From $53, Maintains Buy Rating	MT
10/02/25	Analyst recommendations: Drax, AstraZeneca, HSBC, Broadcom, Tesla...
10/02/25	Analyst recommendations: Aspen, Amazon, Mattel, Broadcom, Tesla…
07/02/25	Deutsche Bank Adjusts Genpact Price Target to $55 From $48, Maintains Hold Rating	MT
07/02/25	TD Cowen Upgrades Genpact to Buy From Hold, Adjusts Price Target to $60 From $45	MT
21/01/25	Jefferies Upgrades Genpact to Buy From Hold, Adjusts Price Target to $55 From $44	MT
21/01/25	Analyst recommendations: Apple, On Holding, Amazon, Palo Alto Networks, Tesla...
11/11/24	Deutsche Bank Adjusts Genpact Price Target to $48 From $37, Maintains Hold Rating	MT
11/11/24	Analyst recommendations: Moderna, Bristol-Myers Squibb Company, Regeneron Pharmaceuticals, Arista Networks...
17/07/24	JPMorgan Upgrades Genpact to Neutral From Underweight, Price Target is $40	MT
17/07/24	Analyst recommendations: American Airlines, Chevron, UnitedHealth, Bank of America, Eli Lilly...
30/01/24	Mizuho Securities Initiates Genpact With Neutral Rating, Price Target is $40	MT
17/01/24	Citigroup Adjusts Price Target on Genpact to $36 From $35, Maintains Neutral Rating	MT
15/12/23	Baird Downgrades Genpact to Neutral From Outperform, Price Target is $38	MT
13/11/23	Wedbush Lowers Genpact's PT to $35 From $45 After Weaker-Than-Expected Q3 Results, Resets Full-Year 2023 Guidance; Keeps Neutral Rating	MT
22/08/23	JPMorgan Downgrades Genpact to Underweight From Neutral, Price Target is $40	MT
11/08/23	Needham Adjusts Genpact Price Target to $50 From $56, Maintains Buy Rating	MT
10/08/23	Deutsche Bank Adjusts Genpact Price Target to $37 From $48, Maintains Hold Rating	MT
10/08/23	BMO Capital Adjusts Price Target on Genpact to $41 From $46, Maintains Market Perform Rating	MT
18/07/23	Citigroup Downgrades Genpact to Neutral From Buy, Adjusts Price Target to $42 From $46	MT
11/05/23	JPMorgan Cuts Genpact's Price Target to $46 From $53, Neutral Rating Kept	MT

More recommendations

Other Business Support Services

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	VISA, INC.					+13.43%
	CINTAS CORPORATION					+11.73%
	UNITED RENTALS, INC.					+17.84%
	NEBIUS GROUP					+21.93%
	PAYPAL HOLDINGS, INC.					+4.61%
	BLOCK, INC.					+29.07%
	SUNBELT RENTALS HOLDINGS, INC.					+13.66%
	CORPAY, INC.					+14.76%
	FISERV, INC.					+29.54%
	Average					+17.40%
	Weighted average by Cap.					+14.80%